1.
Frontiers of Medicine
;
(4): 608-620, 2021.
Artículo
en Inglés
| WPRIM
| ID: wpr-888743
RESUMEN
t(8;21)(q22;q22) acute myeloid leukemia (AML) is a highly heterogeneous hematological malignancy with a high relapse rate in China. Two leukemic myeloblast populations (CD34